Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Xylem $1.5B Debt Financing with Deutsche Bank Trust Company Americas
Xylem Inc. completed a public offering of $1.5 billion in senior notes across three tranches: $500 million of 5.250% notes due 2029, $500 million of 5.450% notes due 2032, and $500 million of 5.850% notes due 2037. The company intends to use the proceeds to finance the previously announced acquisition of the Cornell Pump and Roper Pump businesses and for general corporate purposes.
Lexeo Therapeutics Signs $8.3M M&A Deal with Mantle Therapeutics Inc.
Lexeo Therapeutics completed its acquisition of Mantle Therapeutics for an upfront consideration of $5.3 million in cash and $3.0 million in common stock. The deal includes contingent payments of up to $13.0 million, consisting of a $1.0 million cash payment and $12.0 million in development and regulatory milestones over a 12-year term.
Apyx Medical announced the publication of results from a prospective clinical study in Plastic and Reconstructive Surgery — Global Open evaluating its Renuvion helium plasma technology. The study demonstrated that Renuvion-treated tissue showed a 30% increase in elastin fiber density and a 34% reduction in inflammation, with 100% of participants reporting high satisfaction and visible improvements in skin quality.
Avalanche Treasury Divestiture to Avalanche, Inc. for $15M
Avalanche Treasury Corporation sold approximately 2.08 million AVAX tokens to the Avalanche (BVI) Foundation for $15 million in gross proceeds. The transaction involved the company's longest-dated locked tokens and the proceeds will be used to reduce debt and for general corporate purposes.
Meridian Holdings provided an update regarding a new Provisional Measure in Brazil that prohibits online betting and casino services and requires the return of funds to bettors. The company confirmed that Brazil represents an immaterial share of its group revenue and that it has been fully compliant with the new regulatory requirements. The measure is currently provisional and requires approval by the Brazilian Congress within 120 days to remain in effect.
Verizon Communications Inc. filed an 8-K under Item 5.02 reporting a leadership change. The filing indicates the departure, election, or appointment of directors or certain officers effective September 25, 2026.
nVent Electric $800M Debt Financing with U.S. Bank Trust Company, National Association
nVent Electric's subsidiary Hoffman Schroff Holdings completed a public offering of $800 million in 6.150% Senior Notes due 2036. The proceeds, along with a $600 million term loan and $250 million revolving facility, are intended to fund the $1.75 billion acquisition of Maverick Power, LLC.
Apimeds Pharmaceuticals US Wins Contract from AQUAE Holdings Pte. Ltd.
Apimeds Pharmaceuticals' subsidiary MindWave Innovations entered into two 12-month technology services agreements to deploy its MindChain blockchain infrastructure. The first agreement with AQUAE Holdings involves powering AQUAEChain for environmental credit management, while the second with Flash Sports & Media involves creating FlashChain for digital broadcasting rights and video assets.
Counterparty
AQUAE Holdings Pte. Ltd. and Flash Sports & Media Holdings, Inc.
Constellation Acquisition Corp I Debt Financing Update with Constellation Sponsor LP
Constellation Acquisition Corp I drew $5,000 from an existing unsecured promissory note with its sponsor to fund a deposit into its trust account. This deposit extends the company's deadline to complete an initial business combination from September 29, 2026, to October 29, 2026. The note is non-interest bearing and matures upon the closing of a business combination.
Advanced Flower Capital Inc. entered into Amendment Number Ten to its Loan and Security Agreement, which increases the aggregate revolver commitments to $130 million for a specified period. The amendment also revises the loan fee structure and sets new conditions for advance rates against credit facilities in the borrower base. After the temporary increase period, the maximum revolver amount will revert to $80 million.
Dynex Capital, Inc. closed an underwritten public offering of 4,800,000 shares of its 9.375% Series D Fixed-Rate Cumulative Redeemable Preferred Stock at a liquidation preference of $25.00 per share. The company raised $120 million in gross proceeds (excluding the underwriters' option for an additional 720,000 shares) to be used for general corporate purposes, including acquiring mortgage-backed securities.
Lifecore Biomedical, Inc. \De\ Wins Contract from Alcon Research, LLC
Lifecore Biomedical extended its contract manufacturing agreement with Alcon Research, LLC, pushing the expiration date from 2031 to December 31, 2034. The amendment establishes Alcon's minimum purchase obligations through the new term and includes a non-compete provision regarding certain products starting in November 2026.
Bluerock Acquisition Corp. II Capital Raise of $172M
Bluerock Acquisition Corp. II closed its initial public offering (IPO) of 17,250,000 units at $10.00 per unit, which included the full exercise of the underwriter's over-allotment option. The offering generated gross proceeds of $172.5 million for the newly formed blank check company (SPAC).
The Board of Directors of InPoint Commercial Real Estate Income, Inc. authorized a gross distribution of $0.0260 per share for all classes of its common stock. The distributions are payable to stockholders of record as of September 30, 2026, and will be paid in cash on or about October 19, 2026.
KKR Infrastructure Conglomerate LLC declared monthly cash distributions for September 2026 across multiple share classes, including $0.3300 per share for Class I, R, and F shares. The distributions are payable on or about October 27, 2026, to shareholders of record as of September 30, 2026.
Concentrix reported Q3 2026 revenue of $2.45 billion, a slight 1.2% decrease year-over-year, but exceeded profitability guidance with a non-GAAP operating margin of 12.6%. The company recorded a significant $1.05 billion non-cash goodwill impairment charge due to its stock price trading range, resulting in a GAAP net loss of $988.1 million. Additionally, the Board increased the quarterly dividend to $0.37 per share.
Term
Q3 2026
Earnings call
Sep 29, 2026, 5:00 PM ET
“This quarter, we reached an inflection point where 50% of our revenue is coming from business we have won and deployed within the last 3 years since the introduction of AI. While we are aggressively disrupting our own traditional business, the underlying new business is stronger and healthier as evidenced by our margin expansion, strong free cash flow and growth of our new services.”
Dyne Therapeutics announced additional one-year clinical data from the Phase 1/2 ACHIEVE trial of z-basivarsen (DYNE-101) for myotonic dystrophy type 1 (DM1), showing sustained functional improvement in myotonia, strength, and mobility. The data showed a 3.6-second relative improvement in hand myotonia at 6 months compared to placebo and divergence from a matched natural history cohort at 12 months. The company remains on track to report topline data from its registrational expansion cohort in Q1 2027 to support a potential BLA submission for U.S. Accelerated Approval in Q3 2027.
The board of directors of Graf Global Corp. has elected to extend the deadline to consummate an initial business combination by one month, from September 27, 2026, to October 27, 2026. This is the first of up to three potential one-month extensions permitted under the company's governing documents, providing additional time to finalize a merger target.
Directors Jeffrey Goldberg and Carmen Volkart have notified Modular Medical that they will not stand for re-election at the upcoming fiscal 2027 annual meeting of shareholders. Their departures are not due to any disagreements with the company's operations, policies, or practices. The transitions will occur upon the expiration of their current terms at the annual meeting.
Century Casinos Divestiture to Highfield Investment Group Inc. for $16.4M
Century Casinos entered into a definitive agreement to sell the racing and gaming operations of Century Mile and Century Downs in Alberta, Canada, to Highfield Investment Group for approximately $16.4 million. The deal includes an amendment to the company's master lease with VICI Properties, reducing Century's annual rent by approximately $7.5 million. The company intends to use the proceeds to reduce its indebtedness and focus on its U.S. growth opportunities.
VistaOne, L.P. sold unregistered limited partnership units for aggregate consideration of approximately $24.2 million as part of its continuous private offering. The sale included Class B, I, R, and S units to third-party investors, with the final unit counts determined based on the Fund's transactional net asset value as of August 31, 2026.
Mr. Dean Sparrow resigned from the Board of Directors effective September 25, 2026, while Ms. Carolina Lacerda and Mr. James Oates were appointed as new independent directors effective September 28, 2026. Both new appointees are designated as audit committee financial experts and will serve until the next annual meeting of shareholders.
Fox Factory Holding Divestiture to Squared Up Holdings, LLC for $225M
Fox Factory Holding Corp. completed the divestiture of its Marucci Business (Wheelhouse Holdings Inc.) to Squared Up Holdings, LLC for an enterprise value of $225 million. The consideration consisted of $200 million in cash and a $25 million subordinated convertible promissory note, with the cash proceeds used to reduce the company's outstanding debt.
Scilex Holding $30M Debt Financing with Vivasor, Inc.
Scilex Holding Company entered into an amendment to an existing promissory note with Vivasor, Inc., increasing the maximum aggregate principal amount of its uncommitted revolving line of credit from $20 million to $30 million. Vivasor is an entity led by Scilex's CEO, Dr. Henry Ji, and the amendment was approved by the company's Board and Audit Committee.
Larimar Therapeutics appointed John B. Harlow, Jr. as President and Chief Operating Officer, effective September 29, 2026. His compensation package includes an initial base salary of $560,000, a $35,000 signing bonus, and a target annual bonus of 40% of his base salary. The agreement also provides for severance benefits including nine months of base salary and COBRA coverage in the event of termination without cause.
Cohen & Steers Income Opportunities REIT, Inc. declared monthly cash distributions for September 2026 across all outstanding share classes. The gross distribution is $0.0435 per share for all classes, with net distributions ranging from $0.0350 to $0.0435 depending on applicable stockholder servicing fees, payable on or about October 22, 2026.
Jaime Cosculluela resigned from the Board of Directors for personal reasons, and Marc Urbach was appointed as an independent director to fill the vacancy. Mr. Urbach will receive a quarterly base fee of $12,000 and a quarterly chair fee of $3,000 for his service on the Board.
Polar Power Wins $60M Contract from Major Tier 1 telecom operator in Southeast Asia
Polar Power received a trial order for 50 propane-fueled DC generators from a major Southeast Asian telecom operator, marking the first phase of a potential five-year deployment program. The total opportunity covers approximately 2,500 sites and is estimated to be worth up to $60 million in revenue if the customer proceeds with the full rollout. The deal follows five years of technical evaluation and field testing aimed at reducing fuel and maintenance costs for off-grid cell sites.
Legacy Education Wins $60M Contract from Major Tier 1 telecom operator in Southeast Asia
Polar Power received a trial order for 50 propane-fueled DC generators from a major Southeast Asian telecom operator, representing the first phase of a potential five-year deployment program. If the customer proceeds with the full program covering 2,500 sites, the opportunity is estimated to represent approximately $60 million in revenue.
Cadrenal Therapeutics held its 2026 Annual Meeting of Stockholders where shareholders elected Quang X. Pham as a Class I director and ratified WithumSmith+Brown, P.C. as the independent auditor. Stockholders also approved an amendment to the 2022 Successor Equity Incentive Plan to increase the share pool by 323,542 shares and authorized the issuance of up to 960,000 shares upon the exercise of certain warrants.